Door-to-needle time is the number of minutes between a patient’s arrival at the emergency department and the moment they receive clot-dissolving medication through an IV. It is most commonly used in the treatment of acute ischemic stroke, where the national target is 60 minutes or less, and in heart attacks caused by a complete coronary artery blockage, where the target is 30 minutes or less. Every minute counts: for stroke patients, each 15-minute delay in treatment is linked to a 7% increase in mortality over the following year.
Why Minutes Matter
The clot-dissolving drugs used in stroke and heart attack emergencies are powerfully time-dependent. They work by breaking apart the blood clot that is blocking flow to the brain or heart, but damaged tissue accumulates rapidly once blood supply is cut off. The sooner the medication reaches the clot, the more tissue survives.
For ischemic stroke specifically, a large study tracking patients over one year found that every 15-minute increase in door-to-needle time was associated with 12% higher odds of never being discharged home and 7% higher all-cause mortality. Even among patients who did eventually go home, each 15-minute delay translated into measurably fewer days spent at home during the following year. Separate analyses have estimated a roughly 4% improvement in clinical outcome and 5% lower odds of death for every 15 minutes shaved off treatment time. These aren’t small margins. In a condition where the brain loses about 1.9 million neurons per minute without blood flow, the clinical difference between a 30-minute and a 60-minute door-to-needle time can be the difference between walking out of the hospital and needing long-term care.
The Steps Inside Those Minutes
Door-to-needle time compresses a complex chain of clinical decisions into a single number. From the moment a patient crosses the emergency department threshold, the clock captures triage (recognizing stroke symptoms and escalating priority), a CT scan of the brain (to confirm the stroke is caused by a clot rather than bleeding), blood work, a physician’s assessment and treatment decision, medication preparation, and finally the IV push of the drug itself. The American Heart Association recommends that the CT scan alone should happen within 25 minutes of arrival.
Hospitals treat suspected stroke with the same urgency as a heart attack or major trauma. A “code stroke” triggers a coordinated team response: the CT scanner is cleared, the stroke neurologist is paged, and pharmacy begins preparing the clot-dissolving medication before results are fully back. Any bottleneck in this chain, whether a delay in getting to the scanner, waiting for a radiologist to read the images, or time spent mixing the drug, adds minutes that directly affect outcomes.
Performance Targets Hospitals Aim For
The baseline national standard, set by guidelines from the American Heart Association and the National Institute of Neurological Disorders and Stroke, is a door-to-needle time under 60 minutes for ischemic stroke. But top-performing hospitals aim much lower. The AHA’s Target: Stroke quality improvement initiative uses tiered benchmarks: 60 minutes as the floor, 45 minutes as an intermediate goal, and 30 minutes as the aspirational target for the highest-performing centers.
For heart attacks (specifically ST-elevation myocardial infarction, or STEMI), the target is tighter. When clot-dissolving medication is the chosen treatment, the ACC/AHA guidelines call for a door-to-needle time within 30 minutes. When the treatment is a catheter-based procedure to physically open the artery instead, the corresponding metric is called “door-to-balloon time,” with a 90-minute target.
What Causes Delays
Several factors consistently push door-to-needle times beyond the recommended window. A nationwide Dutch audit identified some patterns that might surprise you. Women had a 17% higher likelihood of delayed treatment, likely because stroke symptoms in women more often include pain and altered consciousness rather than the classic one-sided weakness, making diagnosis less straightforward. Patients under 50 were 38% more likely to experience severe delays because strokes are less expected in younger people, and doctors spend more time ruling out conditions that mimic stroke.
Arriving at the hospital during off-hours (nights, weekends, holidays) increased the odds of delay by 12%, reflecting reduced staffing and limited access to specialists. Larger comprehensive stroke centers, despite having more resources, actually showed higher rates of severe delay, possibly because they receive the most complex and critically ill patients who require more diagnostic workup before treatment can begin.
How Hospitals Are Getting Faster
One of the most effective tools for reducing door-to-needle time doesn’t happen inside the hospital at all. When paramedics identify a likely stroke in the field and radio ahead to the emergency department, the receiving hospital can mobilize its stroke team before the patient arrives. Studies show pre-hospital notification cuts door-to-imaging time by about 10 minutes and door-to-needle time by roughly 12 minutes, bringing the average down from 42 minutes to under 30.
Inside the hospital, a significant recent development is the switch from one clot-dissolving drug to another. The older standard medication requires mixing and then a continuous one-hour IV infusion. A newer alternative is given as a single rapid injection, which is far simpler to prepare and administer. Hospitals that have made this switch have seen median door-to-needle times drop by 6 to 17 minutes depending on the institution, with one study showing times fall from 58 minutes to 41 minutes. Beyond faster delivery, patients treated with the newer drug showed slightly better functional outcomes at 90 days.
Other internal strategies include placing the CT scanner closer to the emergency entrance, allowing lab work to be drawn simultaneously with imaging rather than sequentially, pre-mixing medications so they’re ready the moment a treatment decision is made, and running stroke simulations so staff can practice the rapid coordination required. Simple workflow changes, like having the emergency physician activate the stroke team directly rather than waiting for a neurologist’s confirmation, can eliminate several minutes of unnecessary handoff.
Door-to-Needle Time as a Quality Measure
Door-to-needle time is one of the most closely tracked quality metrics in emergency medicine. Hospitals participating in national registries report their times, and the data is used for accreditation, public reporting, and internal quality improvement. If you or a family member is choosing between hospitals for stroke care, this metric is one of the most meaningful indicators of how quickly and effectively a facility responds to a stroke emergency. Many stroke-certified hospitals publish their median door-to-needle times, and the designation “comprehensive stroke center” or “primary stroke center” signals that a facility has met specific infrastructure and performance standards, though as noted above, complexity of cases at larger centers can sometimes affect their raw numbers.